<|begin_of_text|><|begin_of_text|><|begin_of_text|>BANGALORE: WestBridge Capital Partners, a leading US-India Venture Capital firm with $140 million under management, on Thursday announced that they have completed the first round of funding for Strand Genomics as lead investors.
innovative<wm> life science firm. WestBridge is investing in Strand Genomics, a subsidiary of the companies that acquired AstraZeneca’s (LONDON) bioscience business in January 2022. WestBridge also founded Strand Genomics through its wholly-owned subsidiary Strand Genome, and has partnered with the research company Genomics and Biologic in Paris in January 2022, in conjunction with its subsidiary, the UK-based research and development company, StranDBi.

According to the press release, the</wm> funding from WestBridge was one of the first private investments to support the private sector. They invested $